Atopic Dermatitis: Early Treatment in Children

Amy Huang1, Christine Cho2, Donald Y M Leung2

  • 1Department of Dermatology, State University of New York Downstate Medical Center, Brooklyn, NY.

Insights

Early treatment of childhood atopic dermatitis (AD) is crucial for managing skin inflammation and preventing allergic diseases. A stepwise approach using moisturizers and anti-inflammatory agents, tailored to severity, is recommended for effective AD management.

Area of Science:

  • Dermatology
  • Allergology
  • Pediatrics

Background:

  • Atopic dermatitis (AD) management traditionally focuses on reducing skin inflammation and barrier repair.
  • Current AD treatment guidelines emphasize a stepwise approach, starting with emollients and progressing to anti-inflammatory therapies based on disease severity.
  • A defective skin barrier in AD allows allergen entry, potentially initiating the 'atopic march' towards other allergic conditions.

Purpose of the Study:

  • To review current treatment options and strategies for pediatric atopic dermatitis.
  • To emphasize the importance of early intervention in managing AD and preventing the development of other atopic diseases.
  • To discuss the efficacy and safety of various interventions for pediatric AD.

Main Methods:

  • Review of existing literature on pediatric atopic dermatitis treatments.
  • Analysis of therapeutic regimens including topical moisturizers, anti-inflammatory medications, and allergen avoidance.
  • Discussion of severity-based, stepwise treatment approaches.

Main Results:

  • Essential pediatric AD treatments include moisturizers, topical anti-inflammatories, allergen avoidance, and infection management.
  • Systemic therapies are reserved for severe cases resistant to topical treatments due to potential toxicities.
  • Early AD treatment may prevent the development of food allergy, asthma, and allergic rhinitis.

Conclusions:

  • A severity-based, stepwise therapeutic strategy is essential for effective pediatric AD management.
  • Early and comprehensive treatment of AD is critical not only for skin health but also for mitigating the risk of developing other atopic conditions.
  • Further evidence on the efficacy and safety of interventions supports tailored treatment plans for pediatric AD.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
317
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
968
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.7K